Latest It Compliance News

BOA Resources advances drilling plans for key lithium and nickel tenements in Western Australia despite delays in heritage and environmental approvals, while actively reviewing its asset portfolio amid IGO's exit from Symons Hill.

SIV Capital Limited reported a positive net cash flow for Q4 FY25 and holds $8.177 million in cash, while evaluating a new acquisition opportunity despite ongoing ASX suspension.

Xstate Resources has divested its Austrian Anshof project to concentrate on its upcoming Diona drilling campaign in Queensland and a planned ASX re-listing backed by a $2-3 million capital raise.

Bounty Oil and Gas reported $1.09 million in oil revenue for FY 2025, boosted reserves to 313,000 barrels, and plans to double production with Surat Basin operations starting late 2025. Meanwhile, a Federal Court challenge looms over its Sydney Basin offshore permit.

Admiralty Resources NL reported a cash balance of $1.738 million at the end of June 2025, supported by financing facilities that provide nearly seven quarters of operational funding. The company’s latest cash flow report reveals ongoing investment in exploration alongside careful management of its loan facilities.

Besra Gold has appointed a new, experienced Board and advanced drilling and metallurgical trials at its Jugan deposit, while awaiting a critical mining lease renewal.

Pilot Energy reports significant progress in transitioning the Cliff Head Oil Field to a carbon storage facility, alongside a major upgrade in WA-481P gas and oil prospective resources and a $6.8 million capital raise.

Reedy Lagoon Corporation has identified several promising gold drill targets at its Burracoppin project while seeking a farm-in partner for its iron venture, signaling a pivotal phase in exploration and development.

Ausmon Resources reports promising assay results from recent drilling programs targeting rare earth elements in South Australia and base metals near Broken Hill, NSW, setting the stage for expanded exploration.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Oakridge International reported robust revenue growth and expanded its partner network in Q4 2025, underpinning a promising outlook in healthcare technology. The company also advanced product innovation aligned with new industry standards.

Botanix Pharmaceuticals confirms material sales and prescription growth data, explaining the timing of its ASX disclosures amid share price fluctuations.